{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:24:22Z","timestamp":1793863462927,"version":"4.6.1"},"reference-count":34,"publisher":"American Association for Cancer Research (AACR)","issue":"22","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772726"],"award-info":[{"award-number":["81772726"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303223"],"award-info":[{"award-number":["82303223"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515220064"],"award-info":[{"award-number":["2021A1515220064"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515110299"],"award-info":[{"award-number":["2022A1515110299"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["A2022492"],"award-info":[{"award-number":["A2022492"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The next-generation androgen receptor (AR) inhibitor enzalutamide is the mainstay treatment for metastatic prostate cancer. Unfortunately, resistance occurs rapidly in most patients, and once resistance occurs, treatment options are limited. Therefore, there is an urgent need to identify effective targets to overcome enzalutamide resistance. Here, using a genome-wide CRISPR-Cas9 library screen, we found that targeting a glycolytic enzyme, phosphoglycerate mutase PGAM2, significantly enhanced the sensitivity of enzalutamide-resistant prostate cancer cells to enzalutamide both in vivo and in vitro. Inhibition of PGAM2 together with enzalutamide treatment triggered apoptosis by decreasing levels of the antiapoptotic protein BCL-xL and increasing activity of the proapoptotic protein BAD. Mechanistically, PGAM2 bound to 14\u20133-3\u03b6 and promoted its interaction with phosphorylated BAD, resulting in activation of BCL-xL and subsequent resistance to enzalutamide-induced apoptosis. In addition, high PGAM2 expression, which is transcriptionally regulated by AR, was associated with shorter survival and rapid development of enzalutamide resistance in patients with prostate cancer. Together, these findings provide evidence of a nonmetabolic function of PGAM2 in promoting enzalutamide resistance and identify PGAM2 inhibition as a promising therapeutic strategy for enzalutamide-resistant prostate cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>PGAM2 promotes resistance to enzalutamide by activating antiapoptotic BCL-xL and suppressing apoptosis, indicating that PGAM2 is a potential target for overcoming enzalutamide resistance in prostate cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-23-0308","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T10:57:09Z","timestamp":1694084229000},"page":"3753-3766","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Targeting the Metabolic Enzyme PGAM2 Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer by Inhibiting BCL2 Signaling"],"prefix":"10.1158","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6644-607X","authenticated-orcid":false,"given":"Zhen","family":"Li","sequence":"first","affiliation":[{"name":"1Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China."},{"name":"2State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China."},{"name":"3Department of Urology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5628-8555","authenticated-orcid":false,"given":"Kang","family":"Ning","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China."},{"name":"2State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0955-9591","authenticated-orcid":false,"given":"Diwei","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China."},{"name":"2State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5447-6843","authenticated-orcid":false,"given":"Zhaohui","family":"Zhou","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China."},{"name":"2State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5612-258X","authenticated-orcid":false,"given":"Junliang","family":"Zhao","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China."},{"name":"2State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5918-687X","authenticated-orcid":false,"given":"Xingbo","family":"Long","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China."},{"name":"2State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6679-8380","authenticated-orcid":false,"given":"Zhenyu","family":"Yang","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China."},{"name":"2State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6114-9752","authenticated-orcid":false,"given":"Dong","family":"Chen","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China."},{"name":"2State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3508-4770","authenticated-orcid":false,"given":"XinYang","family":"Cai","sequence":"additional","affiliation":[{"name":"4Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2174-2193","authenticated-orcid":false,"given":"Lexuan","family":"Hong","sequence":"additional","affiliation":[{"name":"4Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1684-4569","authenticated-orcid":false,"given":"Luyao","family":"Zhang","sequence":"additional","affiliation":[{"name":"4Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6581-8151","authenticated-orcid":false,"given":"Fangjian","family":"Zhou","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China."},{"name":"2State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8074-789X","authenticated-orcid":false,"given":"Jun","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China."},{"name":"2State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1795-7242","authenticated-orcid":false,"given":"Yonghong","family":"Li","sequence":"additional","affiliation":[{"name":"1Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, China."},{"name":"2State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"key":"2023111508155045800_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.eururo.2022.04.002","article-title":"Management of patients with advanced prostate cancer: report from the advanced prostate cancer consensus conference 2021","volume":"82","author":"Gillessen","year":"2022","journal-title":"Eur Urol"},{"key":"2023111508155045800_bib2","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/pros.22674","article-title":"Enzalutamide, an androgen receptor signaling inhibitor, induces tumor regression in a mouse model of castration-resistant prostate cancer","volume":"73","author":"Guerrero","year":"2013","journal-title":"Prostate"},{"key":"2023111508155045800_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrc2297","article-title":"Diagnosing and exploiting cancer's addiction to blocks in apoptosis","volume":"8","author":"Letai","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"2023111508155045800_bib4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"2023111508155045800_bib5","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.1210\/en.2006-0502","article-title":"Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak","volume":"147","author":"Castilla","year":"2006","journal-title":"Endocrinology"},{"key":"2023111508155045800_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.semcancer.2015.08.005","article-title":"Therapy escape mechanisms in the malignant prostate","volume":"35","author":"Santer","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"2023111508155045800_bib7","first-page":"1567","article-title":"Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers","volume":"148","author":"Krajewska","year":"1996","journal-title":"Am J Pathol"},{"key":"2023111508155045800_bib8","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/pros.23843","article-title":"Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide","volume":"79","author":"Pilling","year":"2019","journal-title":"Prostate"},{"key":"2023111508155045800_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0378-1119(00)00597-7","article-title":"Mouse phosphoglycerate mutase M and B isozymes: cDNA cloning, enzyme activity assay and mapping","volume":"264","author":"Zhang","year":"2001","journal-title":"Gene"},{"key":"2023111508155045800_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1673-8527(08)60036-3","article-title":"Assignment and expression patterns of porcine muscle-specific isoform of phosphoglycerate mutase gene","volume":"35","author":"Qiu","year":"2008","journal-title":"J Genet Genomics"},{"key":"2023111508155045800_bib11","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/s42255-020-00285-4","article-title":"Nuclear metabolism and the regulation of the epigenome","volume":"2","author":"Boon","year":"2020","journal-title":"Nat Metab"},{"key":"2023111508155045800_bib12","doi-asserted-by":"crossref","first-page":"107518","DOI":"10.1016\/j.celrep.2020.03.082","article-title":"Phosphoglycerate mutase 1 activates DNA damage repair via regulation of WIP1 activity","volume":"31","author":"Ohba","year":"2020","journal-title":"Cell Rep"},{"key":"2023111508155045800_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cmet.2020.12.015","article-title":"The evolving landscape of noncanonical functions of metabolic enzymes in cancer and other pathologies","volume":"33","author":"Xu","year":"2021","journal-title":"Cell Metab"},{"key":"2023111508155045800_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.canlet.2020.05.007","article-title":"GLUT1 is an AR target contributing to tumor growth and glycolysis in castration-resistant and enzalutamide-resistant prostate cancers","volume":"485","author":"Wang","year":"2020","journal-title":"Cancer Lett"},{"key":"2023111508155045800_bib15","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nprot.2017.016","article-title":"Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening","volume":"12","author":"Joung","year":"2017","journal-title":"Nat Protoc"},{"key":"2023111508155045800_bib16","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1158\/0008-5472.CAN-13-3615","article-title":"Oxidative stress activates SIRT2 to deacetylate and stimulate phosphoglycerate mutase","volume":"74","author":"Xu","year":"2014","journal-title":"Cancer Res"},{"key":"2023111508155045800_bib17","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/1078-0432.CCR-16-0718","article-title":"BIRC6 targeting as potential therapy for advanced, enzalutamide-resistant prostate cancer","volume":"23","author":"Luk","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2023111508155045800_bib18","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.1038\/s41598-018-25798-7","article-title":"Eukaryotic translation initiation factor 4 gamma 1 (eIF4G1) is upregulated during prostate cancer progression and modulates cell growth and metastasis","volume":"8","author":"Jaiswal","year":"2018","journal-title":"Sci Rep"},{"key":"2023111508155045800_bib19","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3390\/cancers13061483","article-title":"Cross-resistance to abiraterone and enzalutamide in castration resistance prostate cancer cellular models is mediated by AR transcriptional reactivation","volume":"13","author":"Simon","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2023111508155045800_bib20","doi-asserted-by":"crossref","first-page":"26033","DOI":"10.1074\/jbc.M110.128371","article-title":"Regulation of prostate cancer cell survival by protein kinase cepsilon involves bad phosphorylation and modulation of the TNFalpha\/JNK pathway","volume":"285","author":"Meshki","year":"2010","journal-title":"J Biol Chem"},{"key":"2023111508155045800_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"2023111508155045800_bib22","doi-asserted-by":"crossref","first-page":"13683","DOI":"10.1038\/s41598-021-93107-w","article-title":"A kinome-centered CRISPR-Cas9 screen identifies activated BRAF to modulate enzalutamide resistance with potential therapeutic implications in BRAF-mutated prostate cancer","volume":"11","author":"Palit S a","year":"2021","journal-title":"Sci Rep"},{"key":"2023111508155045800_bib23","doi-asserted-by":"crossref","first-page":"101015","DOI":"10.1016\/j.xcrm.2023.101015","article-title":"A kinome-wide CRISPR screen identifies CK1\u03b1 as a target to overcome enzalutamide resistance of prostate cancer","volume":"4","author":"Liu","year":"2023","journal-title":"Cell Rep Med"},{"key":"2023111508155045800_bib24","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1158\/0008-5472.CAN-21-3565","article-title":"A genome-wide CRISPR activation screen identifies PRRX2 as a regulator of enzalutamide resistance in prostate cancer","volume":"82","author":"Rodr\u00edguez","year":"2022","journal-title":"Cancer Res"},{"key":"2023111508155045800_bib25","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1039\/b705113a","article-title":"Mechanistic and structural requirements for active site labeling of phosphoglycerate mutase by spiroepoxides","volume":"3","author":"Evans","year":"2007","journal-title":"Mol Biosyst"},{"key":"2023111508155045800_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1476-4598-9-81","article-title":"Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma","volume":"9","author":"Ren","year":"2010","journal-title":"Mol Cancer"},{"key":"2023111508155045800_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2021.09.007","article-title":"Metabolic shift to serine biosynthesis through 3-PG accumulation and PHGDH induction promotes tumor growth in pancreatic cancer","volume":"523","author":"Itoyama","year":"2021","journal-title":"Cancer Lett"},{"key":"2023111508155045800_bib28","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41586-020-2183-2","article-title":"The gluconeogenic enzyme PCK1 phosphorylates INSIG1\/2 for lipogenesis","volume":"580","author":"Xu","year":"2020","journal-title":"Nature"},{"key":"2023111508155045800_bib29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molcel.2017.06.008","article-title":"Nuclear Acetyl-CoA production by ACLY promotes homologous recombination","volume":"67","author":"Sivanand","year":"2017","journal-title":"Mol Cell"},{"key":"2023111508155045800_bib30","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1084\/jem.20190158","article-title":"Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis","volume":"216","author":"Dai","year":"2019","journal-title":"J Exp Med"},{"key":"2023111508155045800_bib31","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s10495-018-1476-5","article-title":"Down-regulation of 14\u20133-3 zeta sensitizes human glioblastoma cells to apoptosis induction","volume":"23","author":"Hashemi","year":"2018","journal-title":"Apoptosis"},{"key":"2023111508155045800_bib32","doi-asserted-by":"crossref","first-page":"100751","DOI":"10.1016\/j.tranon.2020.100751","article-title":"The JNK inhibitor AS602801 synergizes with enzalutamide to kill prostate cancer cells in vitro and in vivo and inhibit androgen receptor expression","volume":"13","author":"Li","year":"2020","journal-title":"Transl Oncol"},{"key":"2023111508155045800_bib33","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.eururo.2019.03.020","article-title":"Genomic drivers of poor prognosis and enzalutamide resistance in metastatic castration-resistant prostate cancer","volume":"76","author":"Chen","year":"2019","journal-title":"Eur Urol"},{"key":"2023111508155045800_bib34","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.biocel.2012.08.013","article-title":"Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile","volume":"44","author":"Vaz","year":"2012","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-23-0308\/3363549\/can-23-0308.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/83\/22\/3753\/3381689\/3753.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/83\/22\/3753\/3381689\/3753.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T03:16:57Z","timestamp":1700018217000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/83\/22\/3753\/729997\/Targeting-the-Metabolic-Enzyme-PGAM2-Overcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":34,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2023,9,7]]},"published-print":{"date-parts":[[2023,11,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-23-0308","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.24564656.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24564653","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24564656","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.24564653.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6931226","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6931226.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,7]]}}}